Strontium
Best-in-class: Strontium Citrate
A bone supplement with a genuinely misleading measurement problem that almost nobody explains.
Strontium quick facts
| Suggested dose | Not recommended without medical guidance. |
| How often | Only under medical guidance - not a self-directed supplement |
| Who it's for | Discuss with a doctor; there are better-evidenced options. |
The measurement artifact is the thing to understand before you are impressed by a result. Strontium is denser than calcium, so a DEXA scan reads bone that has incorporated it as denser than it truly is — reported density gains substantially overstate the real structural change. Take away from calcium, since they compete for the same absorption pathway. The pharmaceutical form used in Europe carried a cardiovascular signal that the citrate sold as a supplement has not been tested for either way.
How Strontium actually works
Strontium sits directly below calcium in the periodic table and substitutes for it in the hydroxyapatite crystal of bone. Beyond acting as a mineral stand-in it appears to have a genuine dual signaling effect — stimulating osteoblast activity while inhibiting osteoclast resorption, possibly through the calcium-sensing receptor. That combination is unusual; most bone agents do one or the other.
Where to get Strontium
Find Strontium on iHerb →The evidence for Strontium
Graded by what exists behind each claim.
✅ Clinically validated
- Strontium ranelate (a prescription drug, not this) showed fracture reduction in trials, but was restricted in Europe over cardiovascular and clotting risk. Strontium citrate, the supplement form, has no equivalent fracture data.
📊 Correlative data
- Strontium ranelate was prescribed in Europe for osteoporosis and had real fracture-reduction data — then post-marketing surveillance found cardiovascular and severe skin reaction signals, and its use was heavily restricted. The supplement salts are different compounds without that outcome data.
🧪 Theoretical / extrapolated benefits
- Strontium sits directly below calcium in the periodic table and substitutes for it in bone.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Strontium actually does
The conversion this element performs is on the measurement, not on the bone, and that is what makes it the most quietly misleading product in the catalog. Strontium sits directly below calcium in group 2 of the periodic table, atomic number 38 against calcium's 20. Its ionic radius is close enough that bone mineral accepts it: strontium adsorbs onto the hydroxyapatite crystal surface and, more slowly, substitutes for calcium within the lattice itself.
Dual-energy X-ray absorptiometry does not measure bone. It measures X-ray attenuation and converts it to a mineral density. Photoelectric absorption scales steeply with atomic number, so a strontium atom absorbs far more energy than the calcium atom it replaced. The scanner's calibration assumes the mineral is calcium hydroxyapatite. Substitute a heavier element into the lattice and the reported density rises without a proportional rise in bone strength. Quantifying bone strontium content is itself a research problem, which is why triple-energy photon-counting imaging methods are being developed to estimate it Tanguay 2025.
The size of that artifact is the number nobody prints. Published corrections in the strontium ranelate literature put the overestimation of areal bone mineral density in the region of 50 percent of the apparent gain after a year of treatment. A person reading a 5 percent improvement on a scan report has no way to know how much of it is mineral and how much is atomic number, and no densitometry report carries a strontium correction.
There is a genuine biological mechanism underneath the artifact, and it is worth separating from it. Strontium activates the calcium-sensing receptor on osteoblasts, which supports differentiation and matrix production, and it reduces osteoclast differentiation by shifting the RANKL to osteoprotegerin ratio. A dual action of that kind is unusual, and it is why strontium ranelate was licensed as a drug in Europe rather than dismissed. Whether the supplement salt reproduces it is the question the comparative work addresses Tomczyk-Warunek 2024.
Absorption and retention are where the pharmacokinetics bite. Strontium and calcium compete for the same intestinal transport, so absorption falls sharply when the 2 are taken together and rises when strontium is taken alone. Absorbed strontium then deposits in bone with a very long residence time and is cleared renally, so intake accumulates over years and a scan taken long after stopping can still be affected.
Which sets up the practical trap. Take strontium away from calcium and absorption improves and the calcium intake worsens; take it with calcium and absorption collapses. There is no timing that gets both, and no label explains the trade Turzanska 2023.
Cell, rodent, human — and where it stops
The drug and the supplement are 2 different salts and only 1 of them has fracture data.
What was established for the drug. Strontium ranelate was licensed in Europe on vertebral and hip fracture reduction data in postmenopausal osteoporosis, at 2 g of the ranelate salt daily, supplying about 680 mg of elemental strontium. Its license was later restricted and then withdrawn from the market over cardiovascular and severe hypersensitivity signals. Animal comparisons against bisphosphonate treatment continue to be published Shi 2021.
What has been compared between salts. Ranelate, citrate and chloride were compared directly on bone mineral density, morphology and microarchitecture in an ovariectomized mouse model of osteoporosis Tomczyk-Warunek 2024, and ranelate and chloride were examined against bone microarchitecture and turnover markers in a preliminary study Turzanska 2023. Those are the studies a page on the citrate salt has to be built from, and they are animal and preliminary work rather than fracture trials.
Here is the obstacle, and it is the salt. Strontium citrate is what supplements sell. No fracture trial has ever been conducted on it. The argument that the strontium ion is the active moiety and the counter-ion is irrelevant is plausible, and it is an argument rather than a result - which is precisely what the comparative salt studies were set up to test Tomczyk-Warunek 2024.
The second obstacle is that the endpoint everybody uses is the one this element corrupts. Almost all supplement-level evidence is densitometric, and densitometry systematically overreads in the presence of bone strontium Tanguay 2025. A literature whose main endpoint is inflated by the intervention is a literature that cannot grade itself.
And the safety signal that ended the drug has never been excluded for the supplement. The cardiovascular concern that restricted strontium ranelate arose in a monitored trial population. No comparable safety dataset exists for strontium citrate at any dose, which is an absence of evidence rather than evidence of absence.
Strontium — which form, and does it matter
The number to read is elemental strontium, and the salts differ by more than 2-fold in how much of it they carry. Strontium citrate is roughly 30 to 35 percent elemental strontium by mass, so a 680 mg citrate capsule delivers around 200 to 230 mg of the element. Strontium ranelate is about 34 percent, and the licensed 2 g daily dose delivered about 680 mg. A supplement at 680 mg of citrate is therefore a fraction of the drug dose, and labels routinely quote whichever number is larger.
The comparative work says the salt is not simply a delivery vehicle. Ranelate, citrate and chloride produced different effects on density, morphology and microarchitecture in the same animal model Tomczyk-Warunek 2024, and ranelate and chloride differed on microarchitecture and turnover markers in the preliminary comparison Turzanska 2023. That is direct evidence against treating the counter-ion as inert.
Timing relative to calcium is a form question in everything but name. Competition for shared intestinal transport means the 2 cannot be taken together without losing strontium absorption, and separating them by several hours is the usual instruction. That instruction is also how somebody ends up under-dosing the calcium their bones actually need.
Elemental purity belongs on this page more than on most. Strontium is a mined mineral and mineral supplements are a documented route for contaminant elements; the elemental profiling of herbal food supplements and the associated risk assessment is the relevant literature Torović 2023. Natural strontium is non-radioactive, and strontium-90 is a fission product with no place in any supplement, which is worth stating because the name alarms people for the wrong reason.
And there is a form that is not sold and would be the honest one. A product declaring its elemental strontium content, its salt, and a warning that it invalidates densitometry would let a buyer make a decision. The card's line - not recommended without medical guidance - is a fair summary of a category with a licensed relative that was withdrawn Shi 2021.
What would have to be true, and how you would know it was not
1. The prediction that exposes the whole problem. A dual-energy X-ray absorptiometry scan at baseline and after 12 months. Prediction: reported bone mineral density rises, and a substantial part of the rise is atomic number rather than mineral Tanguay 2025. The result will look like success, and that is the point: this is the measurement that can no longer be trusted.
2. The prediction that would tell you something real. Bone turnover markers rather than density: procollagen type 1 N-terminal propeptide for formation and C-terminal telopeptide for resorption, at baseline, 3 months and 12 months. Prediction: if the dual mechanism operates, formation holds or rises while resorption falls Turzanska 2023. Turnover markers are not distorted by atomic number, which is exactly why they are the right endpoint here.
3. The prediction that cuts against the product. Predict no change in fracture incidence, because no fracture trial has ever been run on the citrate salt Tomczyk-Warunek 2024. Fracture is the outcome that matters and it is the one the supplement literature has never measured.
4. The calcium prediction, which is the avoidable harm. Track dietary and supplemental calcium intake for 2 weeks before starting and again at 3 months. Prediction: total calcium intake falls, because the separation instruction pushes calcium doses out of the routine. Losing calcium to gain strontium is the wrong trade and it is the commonest one in this category.
5. The prediction about stopping, and it is the one that makes this decision hard to reverse. Predict that a scan taken 2 years after stopping is still affected, because bone strontium has a long residence time and the incorporated element leaves slowly. Anyone whose bone density will be used to make a treatment decision in the next few years should know that before starting.
What nobody has tested yet
Nobody has run a fracture trial on strontium citrate. The entire supplement category rests on transferring a drug's data to a different salt at a lower dose Shi 2021. That trial would be expensive and it is the only thing that would settle the question.
Nobody publishes a strontium correction with a scan report. The physics is understood and imaging methods to quantify bone strontium are being developed Tanguay 2025. No clinical densitometry service applies a correction, so every reported density in a strontium user is uninterpretable in practice.
Nobody has excluded the cardiovascular signal for the supplement. The concern that restricted the licensed drug has never been examined at supplement doses in any cohort, which means the risk is neither demonstrated nor ruled out.
And nobody has established a dose-response for the citrate salt. Products range from about 200 to 680 mg of elemental strontium daily with no comparative study behind the choice, and the salt comparisons that exist are in animals Tomczyk-Warunek 2024 Turzanska 2023.
Strontium — its own safety story, not its category's
The risk unique to this product is not a toxicity. It is that it destroys the instrument used to decide whether a person needs treatment. Bone density is how osteoporosis is diagnosed, how fracture risk is estimated and how treatment decisions are made. Strontium inflates that number by physics Tanguay 2025, so somebody taking it can look like they no longer need therapy while their fracture risk is unchanged. That is a diagnostic harm, and it is the reason to tell any doctor ordering a scan.
The cardiovascular signal belongs on this page even though it comes from the drug. Strontium ranelate's license was restricted over myocardial infarction and venous thromboembolism signals, and no one has shown that the citrate salt at supplement doses is free of them. Anyone with established coronary disease, cerebrovascular disease or a thrombotic history should treat this as a prescriber's decision Shi 2021.
The severe hypersensitivity syndrome is rare and worth naming because of what it looks like. Drug reaction with eosinophilia and systemic symptoms was described with the licensed drug: a rash appearing 3 to 6 weeks after starting, with fever and organ involvement. Any widespread rash with fever after starting is a stop and seek care situation rather than a wait and see one.
Kidney function matters because clearance is renal. Strontium is excreted by the kidney and accumulates when clearance falls, which makes chronic kidney disease a categorically different risk position Torović 2023.
And the interaction that undermines the purpose. Strontium competes with calcium for absorption, so the timing rules that make it work make calcium intake harder to hit, and it also chelates tetracycline and quinolone antibiotics the way calcium does. Nothing here is medical advice or a diagnosis of osteoporosis or of any other condition, and none of these statements has been evaluated by the Food and Drug Administration.
Sources read for this page
- Tomczyk-Warunek A. Influence of Various Strontium Formulations (Ranelate, Citrate, and Chloride) on Bone Mineral Density, Morphology, and Microarchitecture: A Comparative Study in an Ovariectomized Female Mouse Model of Osteoporosis. Int J Mol Sci 2024 · PMID 38612883
- Turzanska K. Strontium Ranelate and Strontium Chloride Supplementation Influence on Bone Microarchitecture and Bone Turnover Markers: A Preliminary Study. Nutrients 2023 · PMID 38201922
- Tanguay J. Triple-energy photon-counting x-ray imaging for bone-strontium estimation: A simulation study. Med Phys 2025 · PMID 40985475
- Shi C. Comparable Effects of Strontium Ranelate and Alendronate Treatment on Fracture Reduction in a Mouse Model of Osteogenesis Imperfecta. Biomed Res Int 2021 · PMID 33506016
- Torović L. Safety Assessment of Herbal Food Supplements: Elemental Profiling and Associated Risk. Foods 2023 · PMID 37509838
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Nothing you will be able to interpret afterwards — and that is the finding rather than a gap in this page. The endpoint for a bone supplement is a DEXA scan, and strontium breaks the scan: it sits directly below calcium in the periodic table, substitutes for calcium in bone, and has a higher atomic number, so it absorbs more X-ray energy. Incorporating it makes the scan read higher without a matching increase in bone strength, and it reads high for as long as the strontium is in the bone rather than for the 3 or 4 months you took it. Take it and the one measurement you were relying on stops meaning what it says.
- How long before it means anything: There is no honest window. Not 12 weeks, and not 12 months. The instrument stays compromised for as long as the strontium is in your skeleton, which is far longer than the months you spend taking it. If you have already taken some, say so before the next scan: a DEXA 6 months after the last capsule is not a clean baseline either, because the strontium is in the bone rather than in the bloodstream.
- What will fool you: The scan itself, which is the trap rather than the escape from it: a density number that improves on paper is exactly what this is bought for, and it can be an artifact of the physics. The second confusion is the name. Strontium ranelate, a prescription drug, did reduce fractures in trials and was then heavily restricted in Europe over cardiovascular and severe skin reaction signals; strontium citrate, the supplement salt, is a different compound with no fracture data of its own. It also competes with calcium for absorption, so anything containing both should be separated by 2 hours. If bone loss is the real question, it belongs with a doctor — and calcium, vitamin D, K2, protein and loading have evidence this does not. A fracture-risk conversation is worth more than 6 months of this.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Strontium — safety & side effects
- GI upset, and headache in some people.
- Strontium ranelate was withdrawn in Europe over cardiovascular and clotting risk. Strontium citrate — the supplement form — has not been studied to the same standard, so its safety is assumed rather than demonstrated.
- It falsely inflates DXA bone density readings because it is heavier than calcium. A scan taken while supplementing overstates your bone density, which is the opposite of useful.
- Competes directly with calcium; separate them, and avoid with kidney disease.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Strontium in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Strontium
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| Zinc, Plasma | Deficiency is common; excess quietly depletes copper |
| Copper, Serum | The mineral zinc supplementation drives down |
| Magnesium, RBC | Serum magnesium looks normal in real deficiency |
| Ferritin | Never supplement iron on a guess — see hemochromatosis below |
The Full Micronutrient Screen panel covers these in one order — 11 markers, $363.60 with the discount applied.
Check results you already have → · All 103 markers A–Z
Strontium — frequently asked questions
What is Strontium?
A bone supplement with a genuinely misleading measurement problem that almost nobody explains.
What is the suggested dose of Strontium?
Not recommended without medical guidance. This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Strontium dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Strontium?
Coach Cam sources Strontium from vetted, top-rated brands on iHerb — use the buy link on this page.
Strontium inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Strontium is used for
Strontium appears under 3 goals in the goal router.
Related Minerals supplements
Where this goes next
Strontium is the bone arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.